Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.13, 2003-01, pp. : 1373-1405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones in the treatment of Type 2 diabetes

By Greenberg Andrew S Pittas Anastassios G

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 529-540

Informa Healthcare

Access to resources Recommend Favorite

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials

By Hernandez Adrian V.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. : 115-128

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus

By Krentz Andrew J.

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 385-411

Adis International

Access to resources Recommend Favorite